Andrew J. Rodenhouse

Andrew J. Rodenhouse

Auto-generated profile, based on publicly available information

Andrew J. Rodenhouse

Department of Orthopaedics and Physical Performance, University of Rochester Medical Center, Rochester, NY, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2025 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
ARAndrew J. Rodenhouse
Andrew J. Rodenhouse
EDEric Davis
Eric Davis
PBPhilomena Burger
Philomena Burger
GNGregg Nicandri
Gregg Nicandri
BDBenedict DiGiovanni
Benedict DiGiovanni
Introduction: Despite recent technological advancements, documentation within the electronic health record (EHR) remains a time-consuming task within orthopaedic surgery and may contribute to provider inefficiency, prolonged work hours, and increased burnout. This study evaluates whether the utilization of an artificial intelligence (AI)–based, ambient documentation system can improve provider efficiency in the EHR during outpatient encounters. Methods: A retrospective, quality-improvement study was conducted using EHR metrics from orthopaedic providers. Primary outcome variables, such as the progress note length, time in notes per day, time on unscheduled days, time outside 7 am to 7 pm , and percent of appointments closed same day, were collected. Postutilization months were compared with the same 4-month interval from the previous calendar year (preutilization) to calculate the difference and percent change. Results: Nineteen providers, including attending orthopaedic surgeons, advanced practice providers, and podiatrists were included, with the average utilization of the AI-tool ranging from 24.0% to 31.4%. The average number of appointments per day in the pre- versus postutilization periods were similar. However, provider efficiency improved across nearly all metrics analyzed. Time in notes per appointment (−3.1 minutes, 41%), notes per day (−16.9 minutes, 31%), time on unscheduled days (−22.3 minutes, 31%), and time outside 7 am to 7 pm (−23.6 minutes, 61%) all decreased. The average progress note length also decreased (590.5 characters, 15%). Conclusion: Use of an ambient, AI-based documentation system has the potential to improve orthopaedic provider efficiency. Increased utilization rates and extended use over time allowed for maximum improvements in provider efficiency. The reduction in afterhours burden seen in this study was remarkable, indicating the potential to have a substantial, positive influence on provider well-being.

3 April 2025 in FASEB BioAdvances
Verified
Journal Article
Open access
ARAndrew Rodenhouse
Andrew Rodenhouse
GSGilbert Smolyak
Gilbert Smolyak
EAEmmanuela Adjei‐Sowah
Emmanuela Adjei‐Sowah
NANeeta Adhikari
Neeta Adhikari
SMSamantha Muscat
Samantha Muscat
ALAlayna E. Loiselle
Alayna E. Loiselle
Satisfactory outcomes after acute tendon injuries are hampered by a fibrotic healing response. As such, modulation of extracellular matrix deposition and remodeling represents an important intervention point to improve healing. During fibrosis, matrix is deposited and remodeled by activated fibroblasts and/or myofibroblasts. Recent work has demonstrated that Ogerin, a positive allosteric modulator of the orphan proton‐sensing GPCR, GPR68, can modulate fibroblast ↔ myofibroblast dynamics in multiple fibroblast populations, including blunting myofibroblast differentiation and facilitating reversion of mature myofibroblasts to a basal fibroblast state in vitro. In the present study, we tested the ability of Ogerin to modulate tendon fibroblast ↔ myofibroblast behavior in vitro and in vivo. Consistent with prior work, Ogerin can both blunt TGF‐β induced tenocyte → myofibroblast differentiation and partially revert mature myofibroblasts to a basal tenocyte state. However, Ogerin treatment from days 8–12 after tendon repair surgery did not inhibit myofibroblast differentiation, and Ogerin treatment from post‐operative days 24–28 did not induce myofibroblast reversion. Moreover, while we expected Ogerin treatment from days 8–12 to impair healing due to blunted extracellular matrix formation, Ogerin treatment improved tendon mechanical properties and altered cell transcriptional profiles and communication patterns in a way that suggests accelerated remodeling and resolution of the repair response, identifying Ogerin as a novel therapeutic approach to improve the tendon healing process.

14 May 2025 in Injury
Verified
Journal Article
Closed access
ARAndrew J. Rodenhouse
Andrew J. Rodenhouse
MVMichael Vella
Michael Vella
JGJohn Gorczyca
John Gorczyca

21 June 2025 in Injury
Verified
Journal Article
Closed access
JBJames D. Brodell
James D. Brodell
ARAndrew J. Rodenhouse
Andrew J. Rodenhouse
HSHashim J.F. Shaikh
Hashim J.F. Shaikh
NJNoah M. Joseph
Noah M. Joseph
JCJeremy T. Cushman
Jeremy T. Cushman
JGJohn T. Gorczyca
John T. Gorczyca

17 January 2026 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
AYAnthony J. Yosick
Anthony J. Yosick
ARAndrew Rodenhouse
Andrew Rodenhouse
KJKyle Jerreld
Kyle Jerreld
SLSashank Lekkala
Sashank Lekkala
CMChristine Massie
Christine Massie
CKConstantinos Ketonis
Constantinos Ketonis

31 July 2024 in Journal of Hand Surgery Global Online
Verified
Journal Article
Open access
ARAndrew J. Rodenhouse
Andrew J. Rodenhouse
ADAkhil Dondapati
Akhil Dondapati
TCThomas J. Carroll
Thomas J. Carroll
CKConstantinos Ketonis
Constantinos Ketonis
Shoulder arthroscopy and arthroplasty are increasingly common procedures used to address shoulder pathologies. This study sought to evaluate the incidence of hand-related pathologies, including carpal tunnel syndrome (CTS), cubital tunnel syndrome (CuTS), trigger finger (TF), de Quervain tenosynovitis, and Dupuytren disease following shoulder arthroscopy and arthroplasty procedures. We hypothesized that patients undergoing shoulder surgery would have a higher incidence of hand-related pathologies within 1 year of surgery compared to controls. This was a retrospective analysis of 12,179 patients who underwent shoulder arthroscopy or arthroplasty surgery that were subsequently diagnosed with CTS, CuTS, TF, de Quervain tenosynovitis, or Dupuytren disease within 1 year after surgery. Relative risk of having associated hand pathologies following shoulder surgery was compared to controls. In total, 10,285 patients underwent shoulder arthroscopy procedures during this period, of whom 815 (7.9%) had an associated hand pathology within 1 year from their shoulder procedure. Arthroscopic surgery was associated with an increased likelihood of having a hand pathology (RR 1.65, 95% CI 1.54–1.76), CTS (RR 1.57, 95% CI 1.42–1.73), CuTS (RR 2.25, 95% CI 1.94–2.61), TF (RR 1.76, 95% CI 1.53–2.03), and Dupuytren disease (RR 2.02, 95% CI 1.54–2.65), but was not associated with a higher likelihood of having de Quervain tenosynovitis. In total, 1,894 patients underwent shoulder arthroplasty procedures during this period, of whom 188 (9.9%) had an associated hand pathology within 1 year. Shoulder arthroplasty was associated with an increased likelihood of having a hand pathology (RR 2.04, 95% CI 1.78–2.34), CTS (RR 2.10, 95% CI 1.72–2.57), CuTS (RR 3.29, 95% CI 2.48–4.39), and TF (RR 1.99, 95% CI 1.47–2.70), but was not associated with an increased likelihood of having de Quervain tenosynovitis or Dupuytren disease. Shoulder arthroscopy and arthroplasty procedures were associated with an increased likelihood of having a CTS, CuTS, or a TF diagnosis made within 1 year of surgery. Only shoulder arthroscopy procedures were associated with a higher likelihood of having Dupuytren disease. Neither shoulder arthroscopy nor arthroplasty procedures were associated with an increased likelihood of a diagnosis of de Quervain tenosynovitis. These associations, however, do not necessarily imply causation, and further investigation is warranted to delineate this relationship. Differential Diagnosis/Symptom Prevalence Study Level 3.